Reduced adipocyte insulin sensitivity in caucasian and asian subjects with coronary heart disease

Diabetic Medicine

Volumn 15, Issue 12, 1998, Pages 1003-1009

  Frost, G S ^a   Keogh, B E ^a   Smith, D ^a   Leeds, A R ^b   Dornhorst, A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Coronary heart disease; Insulin resistance; Non esterified fatty acids

Indexed keywords

ADIPOCYTE; ADULT; AGED; ARTICLE; ASIAN; CELL METABOLISM; DISEASE ASSOCIATION; FEMALE; GLUCOSE TRANSPORT; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE;

ADIPOCYTES; ADOLESCENT; ADULT; AGED; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CELLS, CULTURED; CHOLESTEROL; CORONARY ARTERY BYPASS; CORONARY DISEASE; DEOXYGLUCOSE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; GREAT BRITAIN; HEART VALVE DISEASES; HUMANS; INSULIN; INSULIN RESISTANCE; KINETICS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 0031768085     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(1998120)15:12<1003::AID-DIA715>3.0.CO;2-2     Document Type: Article

References (28)

1. Despres J-P, Lamarche P, Mauriege P, Cantin B, Dagenais GR, Sital M, Lupien P-J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-457.
2. Kooner JS, Baliga KR, Wilding J, Peart S, Aitman TJ, Scott J. Metabolic phenotypes for genetic analysis in coronary heart disease. Circulation 1995; 92 (suppl 1): 1-16 0076.
3. Frayn KN, Williams CM, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci 1996; 90: 243-253.
4. Kashiwagi A, Borgardus C, Lillioja S, Huecksteadt TP, Brady D, Verso MA, Foley JE. In vitro insensitivity of glucose transport and antilipolysis to insulin due to receptor and postreceptor abnormalities in obese Pima Indians with normal glucose tolerance. Metabolism 1984; 33: 772-777.
5. Frost G, Keogh B, Smith D, Akinsanya K, Leeds A. The effect of low glycaemic carbohydrate on insulin and glucose response in vitro and in vivo in patients with coronary heart disease. Metabolism 1996; 45: 669-672.
6. Garvey WT, Huecksteadt TP, Matthaei S, Olefsky JM. Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. J Clin Invest 1980; 81: 1528-1536.
7. Foley JE. Clarke W, eds. Methods in Diabetes Research 2, 2nd edn. New York: Lamer and Polsh; 1986; J, Measurement of in vitro glucose transport and metabolism in isolated human adipocytes. 213-241.
8. Albane J, Ekins RP, Martiz G, Turner RC. A sensitive precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free moieties. Acta Endocrinol 1972; 70: 487-509.
9. Duncan MH, Singh BM, Wise P, Alaghband-Zadeh J. A simple measure of insulin resistance. Lancet 1995; 346: 120-121.
10. Prato SD, Pozzilli P. FIRI: fasting or false insulin resistance index. Lancet 1995; 347: 132.
11. Reaven GM. The role of insulin resistance and hyperinsulinemia in coronary heart disease. Metabolism 1992; 41: 16-19.
12. Sheu WH, Jeng CY, Shieh SM, Fuh MM, Shen DD, Chen YD, Reaven GM. Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am J Hypertens 1992; 5: 444-448.
13. Young MH, Chii-Yuan J, Wayne SHH, Shyh-Ming S, Martin F, Chen IYD, Reaven GM. Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with angiographically demonstrated coronary heart disease. Am J Cardiol 1994; 72: 458-460.
14. Frayn KN, Coppack SW. Insulin resistance, adipose tissue and coronary heart disease. Sci Colch 1992; 82: 1-8.
15. Bjorntrop P. 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Atherosclerosis 1990; 104: 93-96.
16. Marin P, Andersson B, Ottosson M, Olbe L, Chowdury B, Kvist H, et al. The morphology and metabolism of intra-abdominal adipose tissue in men. Metabolism 1992; 41: 1242-1248.
17. Frost G, Leeds A, Trew G, Margara R, Dornhorst A. Insulin sensitivity in women at risk of coronary heart disease and the effect of a low glycaemic index diet. Metabolism 1998; in press.
18. Abate N, Garg A, Peahock RM, Stray-Gundersen I, Grundy SM. Relationships of generalised and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96: 88-98.
19. Knapper JME, Puddicombe SM, Morgan LM, Fletcher JM. Investigations into the actions of glucose-dependent insulinotropic polypeptides and glucagon-like peptide-1(7-36)amide on lipoprotein lipoprotein lipase activity in expiants of rat adipose tissue. J Nutr 1996; 125: 183-188.
20. Nasland B, Bernstrom K, Lundin A, Arner P. Release of small amounts of free fatty acids from human adipocytes as determined by chemiluminescence. J Lipid Res 1993; 34: 633-641.
21. Foley JE, William GH. Comparison of body composition, adipocyte size and glucose and insulin concentrations in Pima Indian and Caucasian children. Metabolism 1987; 36: 576-579.
22. Cleland SJ, Peitie JR, Ueda S, Dorridan CA, Connell JM, et al. FIRI: A fair assessment insulin resistance index? Lancet 1996; 347: 770.
23. Shen DC, Shieh SM, Fuh MM, Wu DA, Chen YD, Reavan GM. Resistance to insulin stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988; 66: 580-583.
24. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
25. Pollare T, Lithell H, Selinus I, Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients [see comments]. Br Med J 1989; 298: 1152-1157.
26. Lithell HO. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 1991; 14: 203-209.
27. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128-1130.
28. Frayn KN, Williams CM, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci 1996; 90: 243-253.